TransLABtor

Insights

Audit-ready trails for lab middleware (CAP / ISO 15189)

How labs build defensible evidence around middleware: rule versions, QC gates, validation records, and release trails — without binder chaos.

  • ISO 15189
  • CAP
  • audit trail
  • lab middleware
  • quality management
  • autoverification

What “audit-ready” means for the middle layer

Accreditation frameworks such as ISO 15189 and CAP expect laboratories to show control of processes that affect examination results. When laboratory middleware owns connectivity, quality gating, or autoverification, auditors reasonably ask:

  • Which rule version was active when this result released?
  • Who changed the mapping, and when?
  • What evidence justified go-live for this assay family?

“Audit-ready” here means retrievable, attributable, and versioned evidence — not a binder of screenshots assembled the night before inspection.

Evidence domains to cover

1. Configuration and change history

  • Driver / interface settings changes
  • Test and fluid mapping changes
  • Autoverification and QC gate rule versions
  • Who approved the change (role + record)

2. Specimen and result lineage

  • Raw frame or message retention policy (as defined by the lab)
  • Hold / release decisions with rule identifiers
  • Manual overrides with operator attribution

3. Validation before use

  • Parallel comparison summaries for AV / QC gates
  • Golden-message regression results for the LIS uplink
  • Sign-off that scope matches what is in production

4. Ongoing monitoring

  • Escape or near-miss review
  • Periodic rule performance review (hold rates by family)
  • Pause / resume of AV as a controlled event

Practical structure (not a product checklist)

Evidence packOwnerCadence
Rule / mapping version exportMiddleware ownerEach change + monthly snapshot
Validation summary (per wave)QA + lab supervisorEach go-live slice
Incident / escape logLab ops + QAContinuous
Access reviewLab ITPer policy

Keep the pack in systems of record you already trust (QMS, document control, ticket system). Middleware should emit evidence; the QMS should govern it.

Failure mode

Screenshots in a shared drive with no version. After a rule tweak, nobody can reconstruct what was live last month. Fix: version identifiers on rules and mappings, and a change ticket for every production edit.

FAQ

Does middleware replace the laboratory’s quality system?

No. It should support evidence collection. Formal compliance remains the deploying organization’s responsibility.

What do auditors usually ask first about AV?

Authority (who owns rules), validation evidence, how exceptions are handled, and how you pause/resume when risk rises.

How long should raw interface logs be kept?

Follow institutional retention and privacy policy. Separate “debug retention” from “clinical / accreditation retention” if needed.

About TransLABtor

TransLABtor provides immutable-style operational audit trails and versionable rules intended to support accreditation workflows. Site validation and certification remain with the laboratory. Contact for evidence-pack discussions.

Questions on middleware, LIS interfaces, or AV policy?

Talk with the engineering team about connectivity, uplink specs, and release controls — without replacing your LIS.